CXCL4, a chemokine upregulated in systemic sclerosis patients, abrogates TLR9 signaling and central tolerance in B cells

被引:0
|
作者
Kioon, Marie Dominique Ah [1 ]
Cakan, Elif [2 ]
Garcia-Carmona, Yolanda [3 ]
Cunningham-Rundles, Charlotte [3 ]
Meffre, Eric [2 ]
Barrat, Franck J. [1 ]
机构
[1] Hosp Special Surg, New York, NY USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Icahn Sch Med Mt Sinai Background, New York, NY USA
来源
JOURNAL OF IMMUNOLOGY | 2023年 / 210卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance
    Cakan, Elif
    Kioon, Marie Dominique Ah
    Garcia-Carmona, Yolanda
    Glauzy, Salome
    Oliver, David
    Yamakawa, Natsuko
    Loza, Andrea Vega
    Du, Yong
    Schickel, Jean-Nicolas
    Boeckers, Joshua M.
    Yang, Chao
    Baldo, Alessia
    Ivashkiv, Lionel B.
    Young, Ryan M.
    Staudt, Louis M.
    Moody, Krishna L.
    Nundel, Kerstin
    Marshak-Rothstein, Ann
    van der Made, Caspar I.
    Hoischen, Alexander
    Hayward, Anthony
    Rossato, Marzia
    Radstake, Timothy R. D. J.
    Cunningham-Rundles, Charlotte
    Ryu, Changwan
    Herzog, Erica L.
    Barrat, Franck J.
    Meffre, Eric
    JOURNAL OF EXPERIMENTAL MEDICINE, 2023, 220 (12):
  • [2] Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α
    Ottria, Andrea
    Zimmermann, Maili
    Paardekooper, Laurent M.
    Carvalheiro, Tiago
    Vazirpanah, Nadia
    Silva-Cardoso, Sandra
    Affandi, Alsya J.
    Chouri, Eleni
    Kroef, Maarten V. D.
    Tieland, Ralph G.
    Bekker, Cornelis P. J.
    Wichers, Catharina G. K.
    Rossato, Marzia
    Mocholi-Gimeno, Enric
    Tekstra, Janneke
    Ton, Evelien
    van Laar, Jaap M.
    Cossu, Marta
    Beretta, Lorenzo
    Perez, Samuel Garcia
    Pandit, Aridaman
    Bonte-Mineur, Femke
    Reedquist, Kris A.
    van den Bogaart, Geert
    Radstake, Timothy R. D. J.
    Marut, Wioleta
    RHEUMATOLOGY, 2022, 61 (06) : 2682 - 2693
  • [3] DISEASE MODIFYING EFFECT OF ILOPROST IN PATIENTS WITH SYSTEMIC SCLEROSIS AND POSSIBLE ROLE OF CXCL4 CHEMOKINE
    Stefanantoni, K.
    Sciarra, I.
    Vasile, M.
    Palazzo, R.
    Frasca, L.
    Valesini, G.
    Riccieri, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 903 - 903
  • [4] Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus
    Gies, Vincent
    Schickel, Jean-Nicolas
    Jung, Sophie
    Joublin, Aurelie
    Glauzy, Salome
    Knapp, Anne-Marie
    Soley, Anne
    Poindron, Vincent
    Guffroy, Aurelien
    Choi, Jin-Young
    Gottenberg, Jacques-Eric
    Anolik, Jennifer H.
    Martin, Thierry
    Soulas-Sprauel, Pauline
    Meffre, Eric
    Korganow, Anne-Sophie
    JCI INSIGHT, 2018, 3 (05):
  • [5] CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis
    Roberto Lande
    Ernest Y. Lee
    Raffaella Palazzo
    Barbara Marinari
    Immacolata Pietraforte
    Giancarlo Santiago Santos
    Yves Mattenberger
    Francesca Spadaro
    Katia Stefanantoni
    Nicoletta Iannace
    Aleksandra Maria Dufour
    Mario Falchi
    Manuela Bianco
    Elisabetta Botti
    Luca Bianchi
    Montserrat Alvarez
    Valeria Riccieri
    Marie-Elise Truchetet
    Gerard C.L. Wong
    Carlo Chizzolini
    Loredana Frasca
    Nature Communications, 10
  • [6] CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis
    Lande, Roberto
    Lee, Ernest Y.
    Palazzo, Raffaella
    Marinari, Barbara
    Pietraforte, Immacolata
    Santos, Giancarlo Santiago
    Mattenberger, Yves
    Spadaro, Francesca
    Stefanantoni, Katia
    Iannace, Nicoletta
    Dufour, Aleksandra Maria
    Falchi, Mario
    Bianco, Manuela
    Botti, Elisabetta
    Bianchi, Luca
    Alvarez, Montserrat
    Riccieri, Valeria
    Truchetet, Marie-Elise
    Wong, Gerard C. L.
    Chizzolini, Carlo
    Frasca, Loredana
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [7] TLR9 INDUCES TOLERANCE TO APOPTOTIC CELLS AND IS RESPONSIBLE FOR INDUCING REGULATORY B CELLS
    Miles, Katherine
    Heaney, Jonathan
    Sibinska, Zaneta
    Salter, Donald
    Savill, John
    Gray, David
    Gray, Mohini
    RHEUMATOLOGY, 2012, 51 : 43 - 43
  • [8] Plasmacytoid Dendritic Cells Are Activated in Systemic Sclerosis and Contribute to the Disease By Inducing Ifnα and CXCL4
    Kioon, Marie-Dominique Ah
    Pelrine, Eliza
    Spiera, Robert F.
    Gordon, Jessica K.
    Barrat, Franck J.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [9] PREDICTIVE VALUE OF LABORATORY AND INSTRUMENTAL FINDINGS IN THE VERY EARLY DIAGNOSIS OF SYSTEMIC SCLEROSIS. ROLE FOR CXCL4 CHEMOKINE
    Cadar, M.
    Angelelli, C.
    Pellegrino, G.
    Stefanantoni, K.
    Palazzo, R.
    Lande, R.
    Frasca, L.
    Riccieri, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 150 - 151
  • [10] Differential signaling by CpG DNA in DCs and B cells: not just TLR9
    Verthelyi, D
    Zeuner, RA
    TRENDS IN IMMUNOLOGY, 2003, 24 (10) : 519 - 522